Botulinum Toxin to Minimize Facial Scarring

Abstract

Chemoimmobilization with botulinum toxin A is an ideal biochemical agent that allows near-total elimination of muscle pull on the healing facial wound. The goal of chemoimmobilization of facial cutaneous wounds is to eliminate dynamic tension on the healing tissues to improve wound healing and minimize scarring for optimal aesthetic results.

Keywords

botulinum toxin - chemoimmobilization - scar - wound healing - facial scar

• References

• 1 Kane M. Botulinum toxin. In: Thorne C, Beasley R, Aston S, Bartlett S, Gurtner G, Spear S, , eds. Grabb & Smith's Plastic Surgery. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007: 475-479
• 2 Scott AB, Rosenbaum A, Collins CC. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 1973; 12: 924-927
• 3 Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980; 87: 1044-1049
• 4 Clark RP, Berris CE. Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis. Plast Reconstr Surg 1989; 84: 353-355
• 5 Carruthers JDA, Carruthers JA. Treatment of glabellar frown lines with clostridium botulinum A exotoxin. Dermatol Surg 1992; 18: 17-21
• 6 Gassner HG, Sherris DA, Otley CC. Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates. Plast Reconstr Surg 2000; 105: 1948-1953 ; discussion 1954–1955
• 7 Gassner HG, Brissett AE, Otley CC , et al. Botulinum toxin to improve facial wound healing: a prospective, blinded, placebo-controlled study. Mayo Clin Proc 2006; 81: 1023-1028
• 8 Zimbler MS, Holds JB, Kokoska MS , et al. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial. Arch Facial Plast Surg 2001; 3: 165-169
• 9 Bansal C, Omlin KJ, Hayes CM, Rohrer TE. Novel cutaneous uses for botulinum toxin type A. J Cosmet Dermatol 2006; 5: 268-272
• 10 Laskawi R. [Botulinum toxin treatment in the head and neck region: current aspects, developments, and problems]. HNO 2007; 55 (6) 437-442
• 11 Arnon SS, Schechter R, Inglesby TV , et al; Working Group on Civilian Biodefense. Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001; 285: 1059-1070
• 12 Scott A. Clostridial toxins as therapeutic agents. In: Simpson LL, , ed. Botulinum Neurotoxin and Tetanus Toxin. New York, NY: Academic Press; 1989: 399-412
• 13 Blitzer A, Binder WJ, Aviv JE, Keen MS, Brin MF. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg 1997; 123: 389-392
• 14 Carruthers A, Carruthers J. Botulinum toxin type A: history and current cosmetic use in the upper face. Semin Cutan Med Surg 2001; 20: 71-84
• 15 Due E, Rossen K, Sorensen LT, Kliem A, Karlsmark T, Haedersdal M. Effect of UV irradiation on cutaneous cicatrices: a randomized, controlled trial with clinical, skin reflectance, histological, immunohistochemical and biochemical evaluations. Acta Derm Venereol 2007; 87: 27-32
• 16 Mandal A. Do malnutrition and nutritional supplementation have an effect on the wound healing process?. J Wound Care 2006; 15: 254-257
• 17 Sherris DA, Larrabee Jr WF, Murakami CS. Management of scar contractures, hypertrophic scars, and keloids. Otolaryngol Clin North Am 1995; 28: 1057-1068
• 18 Larrabee Jr WF, Sutton D. The biomechanics of advancement and rotation flaps. Laryngoscope 1981; 91: 726-734
• 19 Larrabee Jr WF, Trachy R, Sutton D, Cox K. Rhomboid flap dynamics. Arch Otolaryngol 1981; 107: 755-757
• 20 Cloquet JH. Traite d'Anatomie Descriptive. Paris, France: Libraire de Crochard; 1832: 313
• 21 Dupuytren G. Traite Theorique et Pratique des. Armes de Guerre. Paris. Baillere 1834; 2: 60-66
• 22 Langer K. On the anatomy and physiology of the skin: I. The cleavability of the skin. Br J Plast Surg 1978; 31 (4) 277-278
• 23 Larrabee Jr WF, Sherris DA. Principles of Facial Reconstruction. Philadelphia, PA: Lippincott-Raven; 1995: 7
• 24 McCarthy JG. Plastic Surgery. Philadelphia: W.B. Saunders; 1990: 43-44
• 25 Sherris DA, Gassner HG. Botulinum toxin to minimize facial scarring. Facial Plast Surg 2002; 18: 35-39
• 26 Lee BJ, Jeong JH, Wang SG, Lee JC, Goh EK, Kim HW. Effect of botulinum toxin type A on a rat surgical wound model. Clin Exp Otorhinolaryngol 2009; 2: 20-27
• 27 Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341: 738-746
• 28 Woodley DT, Chen JD, Kim JP , et al. Re-epithelialization. Human keratinocyte locomotion. Dermatol Clin 1993; 11: 641-646
• 29 Clark RAF , Ed. The Molecular and Cellular Biology of Wound Repair. 2nd ed. New York, NY: Plenum Press; 1996
• 30 Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975; 78: 71-100
• 31 Hunt TK , Ed. Wound Healing and Wound Infection: Theory and Surgical Practice. New York, NY: Appleton-Century-Crofts; 1980
• 32 Taylor JA. Wound healing. In: Blueprints Plastic Surgery. Malden, MA: Blackwell Publishing; 2005: 17-31
• 33 Gassner HG, Sherris DA. Chemoimmobilization: improving predictability in the treatment of facial scars. Plast Reconstr Surg 2003; 112: 1464-1466
• 34 Wilson AM. Use of botulinum toxin type A to prevent widening of facial scars. Plast Reconstr Surg 2006; 117: 1758-1766 ; discussion 1767–1768
• 35 Gassner HG, Sherris DA, Friedman O. Botulinum toxin-induced immobilization of lower facial wounds. Arch Facial Plast Surg 2009; 11: 140-142
• 36 Tollefson TT, Senders CM, Sykes JM, Byorth PJ. Botulinum toxin to improve results in cleft lip repair. Arch Facial Plast Surg 2006; 8: 221-222
• 37 Gassner HG, Sherris DA. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study. Mayo Clin Proc 2000; 75: 701-704
• 38 Gassner HG, Sherris DA, Moe KS , et al. The role of botulinum toxin in wound healing. In: Jankovic J, Albanese A, Atassi MZ, , et al, eds. Botulinum Toxin, Therapeutic Clinical Practice & Science. Philadelphia, PA: Elsevier Saunders Inc.; 2009: 339-348